NanoString Technologies Names CMO
An industry veteran and clinical oncologist, Dr. Cowens will drive the development of the company’s pipeline of molecular diagnostics for cancer.
Read MoreSearch Results for: prostate cancer
Biocare, Jackson Foundation Strike Exclusive Distribution Agreement
Posted by Clinical Lab Products | Jan 20, 2011 | Cancer, Miscellaneous |
Biocare Medical and the Henry M Jackson Foundation for the Advancement of Military Medicine announce exclusive distribution agreement for a highly specific monoclonal antibody.
Read MoreBar Harbor BioTechnology to Launch Diagnostic Division
Posted by Clinical Lab Products | Dec 6, 2010 | Cancer, Miscellaneous |
This new division will create genetic diagnostic tests that determine an individual’s risk of developing a disease.
Read MoreGen-Probe Files US Regulatory Application for PROGENSA PCA3 Assay
Posted by Clinical Lab Products | Sep 23, 2010 | Cancer, Miscellaneous |
Gen-Probe announced that the Company has submitted a Premarket Approval Application (PMA) to the FDA for its PROGENSA PCA3 assay.
Read MoreMiraculins Launches ELISA Kit for Detection of PSP94 in Urine
Posted by Clinical Lab Products | Aug 13, 2010 | Cancer, Miscellaneous |
Miraculins Inc announces the launch of its PSP94 Immunoassay for urine specimens, a research use only (RUO) tool utilizing enzyme linked immunosorbent assay (ELISA) for the detection of PSP94 in urine.
Read More